p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells

  1. Hiroaki Kawasaki1,2,3,4,
  2. Jun Song1,
  3. Richard Eckner5,
  4. Hideyo Ugai1,
  5. Robert Chiu6,
  6. Kazunari Taira2,3,4,
  7. Yang Shi7,
  8. Nic Jones8, and
  9. Kazunari K. Yokoyama1,9
  1. 1Tsukuba Life Science Center, The Institute of Physical and Chemical Research (RIKEN), Tsukuba 305, Japan; 2National Institute for Advanced Interdisciplinary Research and 3National Institute of Bioscience and Human Technology, Agency of Industrial Science & Technology, MITI, Tsukuba 305, Japan; 4Institute of Applied Biochemistry, University of Tsukuba, Tsukuba 305, Japan; 5Institute for Molecular Biology, University of Zurich, Zurich, Switzerland; 6Department of Surgery/Oncology, University of California, Los Angeles, School of Medicine and Jonsson Comprehensive Cancer Center, Los Angeles, California 90024 USA; 7Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 USA; 8Laboratory of Gene Regulation, Imperial Cancer Research Fund, London WC2A 3PX, UK

Abstract

Transcriptional activation of the c-jun gene is a critical event in the differentiation of F9 cells. In our previous studies we characterized an element [differentiation response element (DRE)] in the c-jun promoter that is both necessary and sufficient to confer the capacity for differentiation-dependent up-regulation. This element binds the differentiation regulatory factor (DRF) complex, of which one component is the adenovirus E1A-associated protein p300. We have now identified activation transcription factor-2 (ATF-2) as a DNA-binding subunit of the DRF complex. p300 and ATF-2 interact with each other in vivo and in vitro. The bromodomain and the C/H2 domain of p300 mediate the binding to ATF-2, which in turn requires a proline-rich region between amino acids 112 and 350 for its interaction with p300. The phosphorylation of the serine residue at position 121 of ATF-2 appears to be induced by protein kinase Cα (PKCα) after treatment of cells with retinoic acid (RA) or induction with E1A. In cotransfection assays, wild-type ATF-2 enhanced the transcription of an E2/tk–luciferase construct, in conjunction with p300–E2. However, a mutant form of ATF-2 with a mutation at position 121 (pCMVATF–2Ser121–Ala) did not. These results suggest that ATF-2 and p300 cooperate in the control of transcription by forming a protein complex that is responsive to differentiation-inducing signals, such as RA or E1A, and moreover, that the phosphorylation of ATF-2 by PKCα is probably a signaling event in the pathway that leads to the transactivation of the c-jun gene in F9 cells.

Keywords

Footnotes

  • 9 Corresponding author.

  • E-MAIL kazunari{at}rtc.riken.go.jp; FAX 81-298-36-9120.

    • Received September 15, 1997.
    • Accepted November 14, 1997.
| Table of Contents

Life Science Alliance